NEW YORK (GenomeWeb) – WuXi Apptec announced today that it has acquired biology contract research organization HD Biosciences (HDB).

HDB is headquartered in Shanghai, China, and operates facilities in Beijing and San Diego. WuXi Apptec said that the acquisition would help strengthen its capabilities in target validation, as well as lead discovery and optimization. HDB also provides hit identification, in vivo pharmacology, and other related services.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The US National Institutes of Health has developed guidelines to gauge whether frail chimpanzees are healthy enough to be moved to a retirement sanctuary.

Osamu Shimomura, who won the 2008 Nobel Prize in Chemistry for his work on green fluorescent protein, has died.

In PLOS this week: analytical approach for finding new genetic associations, analysis of Streptococcus pyogenes-infecting viruses, and more.

Stat News reports that the head of IBM Watson Health is leaving her post.